Kahn, leading India's best-known agri-focussed venture capital firm, is readying for his third fund, at $150 million, to expand investments into game-changing startups in the sector
Legal experts, technologists and civil society activists believe while some elements of the rules work, many are ambiguous, cumbersome and strenuous on fundamental rights
The Centre's ambitious plan of 200 crore doses by the year-end will require ramp-up of production, approval and manufacturing of new vaccines, and removing hesitancy and inequities in access. How realistic are the targets?
Tiger Global's aggressive big bets this year might do a world of good for the American hedge fund major, although riding the beast can prove tricky at times for founders
India's cryptocurrency industry is once again in a regulatory flux following fresh concerns voiced by RBI Governor Shaktikanta Das. As banks keep crypto-related transactions at an arm's length, government intervention is urgently needed to frame guidelines for the sector
Through innovation and pivots, these startups are helping rural India, which has little or no access to healthcare including, hospitals, doctors, diagnostics, or medicines, cope with the pandemic
The regular occurrence of cyclones off the warm waters highlight the pressing concern for India's Western Coast as surface sea temperatures rise. The possibility of severe cyclonic damage to natural resources is just as grave as it is for man-made infrastructure
From a paltry 4.8 percent market share in FY20, Tata Motors today has a market share of over 9 percent. The company, with a 69 percent growth in sales in FY21, is now busy scripting a remarkable turnaround
In 2015, the founder of TaxiForSure had no choice but to sell the capital-starved startup to rival Ola. The serial entrepreneur learnt his lesson: Start a business that doesn't guzzle capital—and it helps if it's an early (desi) bird
Billionaire Vijay Shekhar Sharma, who always wanted to get to breakeven before taking his company public, is now looking at a timeline where the IPO happens first. The listing could see Chinese investor Alibaba Group dilute its stake or even exit India's most valuable startup
There are drugs that continue to be on the health ministry's treatment protocol despite evidence not inspiring confidence, while the regulator is approving medicines without following due scientific process, experts say